MediaTek and Unisoc Post Double-digit Shipment Growth in Smartphone Apps Processors
Qualcomm Increases Revenue Share BOSTON–(BUSINESS WIRE)–The global smartphone applications processor (AP) market grew 35 percent…
Qualcomm Increases Revenue Share BOSTON–(BUSINESS WIRE)–The global smartphone applications processor (AP) market grew 35 percent…
PRESS RELEASE August 5, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced…
Enrollment ongoing in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate,…
Milford, Delaware–(Newsfile Corp. – August 5, 2022) – The ShibaDoge team is excited to announce…
curaJOY launches a free emotional wellness directory which gives marginalized communities access to global mental…
As Florida adds more regulations to combat cyber threats, cybersecurity firm 2Secure Corp (646-560-5083) launches…
LOS ANGELES, CA, Aug 5, 2022 – (ACN Newswire) – Internationally premiering at the 79th…
Neurocrine to conduct placebo-controlled Phase 2 study to investigate NBI-1117568 (formerly HTL-0016878) as a potential…
TORONTO–(BUSINESS WIRE)–Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a rapidly growing financial…
COLUMBUS, Ga.–(BUSINESS WIRE)–Synovus Financial Corp. (NYSE: SNV) today announced the pricing of its previously-announced underwritten…
— Secured $68.9 million in committed financing through a combination of equity and non-dilutive debt…
BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
Company expects to report results of preclinical MPS-1 studies in second half of 2022 to…
Reported positive initial data from ongoing pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric…
IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin Lymphoma Cellectis…
– Recently-announced company restructuring focuses internal efforts on wholly-owned next-generation conditionally activated therapeutics, extending cash…
Cash balance of $312.2M expected to fund operations into 2025 CAMBRIDGE, Mass., Aug. 04, 2022…
SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage…
Mississauga, Ontario–(Newsfile Corp. – August 4, 2022) – Two Hands Corporation. (OTC Pink: TWOH) (“Two…
RICHMOND, Va.–(BUSINESS WIRE)–McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver…